The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.

S. Rutherford,J. Leonard

2017-05-16

Oncology

Abstract:Given the benefit of rituximab to patients, it will be important that the use of biosimilar compounds not compromise the efficacy of treatment. However, measures to improve access to anti-CD20 therapy in a cost-effective manner will clearly provide benefit to patients with lymphoma.

What problem does this paper attempt to address?

Suction Drainage for Anastomotic Leakage After Ivor Lewis Esophagectomy

Merel Lubbers,Marc J van Det,David Crull,Andries van der Linden,Anton A Vrij,Ewout A Kouwenhoven

DOI: https://doi.org/10.1097/SLE.0000000000001130

2023-02-01

Abstract:Background: Anastomotic leakage is one of the most life-threatening complications after Ivor Lewis esophagectomy (ILE), with various treatment strategies. Endoscopic techniques are emerging as a less invasive alternative to surgery. Among the current endoscopic techniques, a single placement of an endoluminal nasogastric tube inside the cavity with controlled suction drainage (SD) seems to be an attractive option. The aim of this study was to evaluate the efficacy of SD as treatment for anastomotic leakage after ILE. Methods: This retrospective analysis was performed among patients who underwent ILE in a high-volume esophageal cancer center in the Netherlands. Patients with an anastomotic leakage that received SD as primary treatment were selected. A nasogastric tube was endoscopically placed into the cavity of the leakage for controlled suction with 15 mm Hg. Results: A total of 34 patients received SD and was successful in 26 patients (77%). Seven patients (21%) developed empyema despite the SD for which additional video-assisted thoracoscopic surgery was performed. Mortality was 5.9% (2 patients) and median intensive care unit and hospital stay were 3 days (1 to 9) and 25 days (14 to 43), respectively. The median time to closure of the leak was 41 days (23 to 65). A total of 16 patients underwent home treatment for a median of 23 (14 to 42) days. Conclusions: Controlled SD seems to be an effective treatment for anastomotic leakage after ILE. This therapy can safely and effectively be completed in an ambulant, outpatient setting.
Outcome of Self-Expanding Metal Stents in the Treatment of Anastomotic Leaks After Ivor Lewis Esophagectomy

Patrick Sven Plum,Till Herbold,Felix Berlth,Hildegard Christ,Hakan Alakus,Marc Bludau,De-Hua Chang,Christiane Josephine Bruns,Arnulf Heinrich Hölscher,Seung-Hun Chon

DOI: https://doi.org/10.1007/s00268-018-4832-2

Abstract:Background: Esophageal anastomotic leakages after Ivor Lewis esophagectomy are severe and life-threatening complications. We analyzed the outcome of using self-expanding metal stents (SEMS) in the treatment of postoperative leakage after esophagogastrostomy. Methods: Seventy patients with esophageal anastomotic leakage after Ivor Lewis esophagectomy for esophageal cancer who had received SEMS treatment between January 2006 and December 2015 at our clinic were identified in this retrospective study. The patients were analyzed according to demographic characteristics, risk factors, leakage characteristics, stent characteristics, stent-related complications, sealing success rate and mortality. Results: Over a 10-year period, 70 patients received SEMS as treatment for postoperative anastomotic leakage after esophagectomy. Technical success of esophageal stenting in anastomotic leakage was achieved in 50 out of 70 cases (71.4%). Sealing success rate was 70% (n = 49) with a median treatment of 28 days (range 7-87). In 20 patients (28.6%), stent-related complications, such as stenosis, dislocation, leakage persistence, perforation or esophagotracheal fistula occurred after the SEMS treatment. Sixty-one patients (87.1%) survived SEMS treatment of esophagogastric anastomotic leakage. Mean follow-up for all patients was 38 months (IQR 10-76), and no significant difference was found in a comparison of the long-term survival rate between patients with successful and unsuccessful SEMS treatment. Conclusions: The management of esophageal anastomotic leaks after Ivor Lewis esophagectomy with SEMS is effective, safe and technically feasible. Aggressive non-surgical management should be considered when developing a treatment plan for stenting.
[STUDY USING RADIOACTIVE CALCIUM (45CA) IN HYPERPARATHYROIDISM].

J. Lievre,J. Camus,J. Bourichon

1965-03-01

Abstract:
Anastomotic Leakages after Surgery for Gastroesophageal Cancer: A Systematic Review and Meta-Analysis on Endoscopic versus Surgical Management

Isabel Azevedo,Raquel Ortigão,Pedro Pimentel-Nunes,Pedro Bastos,Rui Silva,Mário Dinis-Ribeiro,Diogo Libânio

DOI: https://doi.org/10.1159/000527769

2023-01-24

Abstract:Introduction: With the increase of esophageal and gastric cancer, surgery will be more often performed. Anastomotic leakage (AL) is one of the most feared postoperative complications of gastroesophageal surgery. It can be managed by conservative, endoscopic (such as endoscopic vacuum therapy and stenting), or surgical methods, but optimal treatment remains controversial. The aim of our meta-analysis was to compare (a) endoscopic and surgical interventions and (b) different endoscopic treatments for AL following gastroesophageal cancer surgery. Methods: Systematic review and meta-analysis, with search in three online databases for studies evaluating surgical and endoscopic treatments for AL following gastroesophageal cancer surgery. Results: A total of 32 studies comprising 1,080 patients were included. Compared with surgical intervention, endoscopic treatment presented similar clinical success, hospital length of stay, and intensive care unit length of stay, but lower in-hospital mortality (6.4% [95% CI: 3.8-9.6%] vs. 35.8% [95% CI: 23.9-48.5%]. Endoscopic vacuum therapy was associated with a lower rate of complications (OR 0.348 [95% CI: 0.127-0.954]), shorter ICU length of stay (mean difference -14.77 days [95% CI: -26.57 to -2.98]), and time until AL resolution (17.6 days [95% CI: 14.1-21.2] vs. 39.4 days [95% CI: 27.0-51.8]) when compared with stenting, but there were no significant differences in terms of clinical success, mortality, reinterventions, or hospital length of stay. Conclusions: Endoscopic treatment, in particular endoscopic vacuum therapy, seems safer and more effective when compared with surgery. However, more robust comparative studies are needed, especially for clarifying which is the best treatment in specific situations (according to patient and leak characteristics).
Outcomes of Esophageal Stent Therapy for the Management of Anastomotic Leaks

Toni S. Carter,Prejesh Philips,Michael Egger,Charles Scoggins,Robert C. G. Martin

DOI: https://doi.org/10.1245/s10434-021-09669-6

IF: 4.339

2021-03-17

Annals of Surgical Oncology

Abstract:BackgroundThe purpose of this study was to present the optimal patient selection for esophageal stenting after esophageal resection to investigate possible factors leading to treatment success or treatment failure in these patients.MethodsThis was a prospective, observational study of patients from January 2005 to May 2019 with an esophageal anastomotic leak that were treated with a self-expandable stent (SES).ResultsA total of 34 patients were treated. All achieved technical success (100%); 33 (97%) achieved clinical success. No patient had to have reoperative surgery based on their leak management. The stenting in-hospital mortality was 0% with 1 patient (2%) with a 90-day mortality from possible leak-related death. Patients had their stents removed with a median of 106 days.ConclusionsStenting for an anastomotic leak after resection offers a safe and effective method of treatment and is successful in the majority of cases. Critical to success is optimal patient selection, adequate leak drainage, and optimal stent selection and placement.

oncology,surgery
Endoscopic Naso-Leakage Drainage: a Safe and Effective Method for the Management of Intrathoracic Anastomotic Leakage after Esophagectomy.

Yi Zhang,Yong-Xing Zhang,Jian-Wei Hu,Guang-Yu Yao,Liang Xue,Hong Fan,Yi-Qun Zhang,Qun Wang

DOI: https://doi.org/10.21037/jtd.2017.08.47

2017-01-01

Journal of Thoracic Disease

Abstract:BACKGROUND:Intrathoracic anastomotic leakage (IAL) remains a major complication of esophagectomy. Main non-surgical options of management include chest drainage and endoscope interventions. This study is aim to present our experience and assess the efficacy of endoscopic naso-leakage drainage (ENLD) in patients with IAL.METHODS:From June 2011 to January 2017, 67 patients who developed IAL after esophagectomy and managed by non-surgical approaches were analyzed retrospectively. IAL was confirmed by clinical presentations combined with the evidence of CT scan, radiography and endoscopy. Thirty-eight patients were treated by conventional chest drainage (CD group) and 29 patients underwent ENLD with or without chest drainage (ENLD group), while other treatments including enteral nutrition and antibiotics had no difference between the two groups. In ENLD group, a 12 Fr naso-leakage tube was placed through the leakage to the bottom of vomica under ultra-slim electronic gastroscope. The naso-leakage tube was then connected to a gastrointestinal decompression device for drainage and was also used for rinse. When the vomica diminished and the drainage was also clean, the naso-leakage tube could be pulled back gradually. Finally, healing of the leakage was confirmed endoscopically. Clinical records of the two groups were analyzed.RESULTS:In ENLD group, naso-leakage tubes were successfully placed under endoscope in all 29 patients without any procedure-related complications. In CD group, the mortality is 7.9% (three patients) and five patients (13.2%) developed to systemic inflammatory response syndrome (SIRS) due to insufficient drainage. While in ENLD group, there was only one patient (3.4%) developed to SIRS and no death was observed, but the difference was not statistically significant. When compared with the CD group, the ENLD group had a shorter healing course (44.2±18.3 vs. 60.5±27.7 days, P=0.008), duration of antibiotics usage (16.4±7.8 vs. 11.8±3.8 days, P<0.001) and duration of fever (4.3±2.2 vs. 9.5±8.6 days, P=0.002).CONCLUSIONS:To our initial experience, ENLD is an ideal option with safety and efficacy in management of IAL after esophagectomy.
Differences in the pattern of anastomotic leakage after oesophagectomy in two high-volume centres

Lars Bo Svendsen,Lone Susanne Jensen,Jakob Holm,Steen Christian Kofoed,Hans Pilegaard,Louise Preisler,Marianne Vinbæk,Bodil Brandt,Morten B Svendsen,Danish Oesophagus, GEJ and Gastric Cancer Group

Abstract:Introduction: Complications to oesophageal and junctional cancer surgery are common and have not diminished much during the past ten years. An unusually high occurrence of anastomotic dehiscence occurred in Denmark in 2009 and 2010 as seen in the national database for oesophagus, cardiac and gastric (ECV) cancer. Material and methods: In accordance with national guidelines, all patients resected for oesophageal and junctional cancer in Denmark from 2003 were prospectively entered into a national database. Data concerning anaesthesia, peri- and post-operative course, complications, re-operations and time spent in intensive care unit were obtained retrospectively from hospital records. An in-depth analysis of data from two high-volume centres performing ECV cancer surgery according to national guidelines was performed. Results: A total of 881 patients (Centre 1: 438; Centre 2: 443) were resected for oesophageal and junctional cancer. A total of 79 patients with anastomotic insufficiency (AI) were detected (Centre 1: 36; Centre 2: 43). By using a grading system, it was shown that AI was more severe and occurred earlier in one centre than in the other. Possible factors of influence are discussed, including neoadjuvant oncological therapy, use of thoracoscopically performed anastomosis and perioperative inotrophic drugs. Conclusion: Thanks to the establishment of a nationwide database in pursuance of national guidelines, it was possible to detect variations in quality of surgery over time, evaluate serious complications early and undertake an in-depth analysis of possible aetiological factors. Particularly, comparison was facilitated by the use of a standardised grading system for complications. Funding: not relevant. Trial registration: not relevant.
Effect of Neoadjuvant Therapy on Endoluminal Vacuum-Assisted Closure Therapy (EVAC) for Anastomotic Leakage After Oesophagectomy

Catharina Fahrenkrog,Sorin Miftode,Ahmed Al-Mawsheki,Fadl Alfarawan,Stella Wilters,Maximilian Bockhorn,Nader El-Sourani

DOI: https://doi.org/10.3390/cancers16213597

2024-10-26

Cancers

Abstract:Background: Anastomotic leakage (AL) is a dreaded complication after oesophagectomy. Endoluminal vacuum-assisted closure therapy (EVAC) has been increasingly used as a first-line treatment for AL. We aimed to identify any potential adverse effects of a neoadjuvant therapy (chemotherapy (CT) or radiochemotherapy (RCT)) on EVAC. Methods: We performed a retrospective cohort study at our tertiary centre between 2013 and 2024. All patients who underwent EVAC for AL after oesophagectomy were included in this study. Parameters such as success rate, length of therapy, number of sponges needed, changes in treatment, and survival were analysed. Results: A total of 29 patients were included, 19 of whom received CT/RCT and 10 of whom received no neoadjuvant treatment (NT). There was no significant difference in patient survival (30-day survival rate CT/RCT n = 1 (5.3%) vs. NT n = 1 (10%), p = 0.632), success rate (CT/RCT n = 15 (78.9%) vs. NT n = 9 (90%), p = 0.454), and length of therapy (CT/RCT vs. NT 24.11 vs. 23.8, p = 0.681), the number of sponges required (CT/RCT vs. NT 6.26 vs. 6.6, p = 0.835), and the need for changing treatment (CT/RCT n = 5 (26.3%) vs. NT n = 1 (10%), p = 0.303). Conclusions: NT did not affect the success rate or length of therapy. Thus, we found no significant influence of CT/RCT on EVAC for AL after oesophagectomy.

oncology
Risk factors for anastomotic leakage in colonic procedures within an ERAS‐protocol. A retrospective cohort study from the Swedish part of the international ERAS‐database

Felix Bjerregaard,Daniel Asklid,Olle Ljungqvist,Anders H. Elliot,Klas Pekkari,Ulf O. Gustafsson

DOI: https://doi.org/10.1002/wjs.12205

IF: 3.282

2024-05-10

World Journal of Surgery

Abstract:Background Research on anastomotic leakage (AL) in colonic procedures within an Enhanced Recovery After Surgery (ERAS) protocol has not yet been conducted. The aim of this study was to identify risk factors for AL after colonic surgery. Methods The study included all consecutively recorded patients operated with colonic resection surgery in the Swedish part of the international ERAS® Interactive Audit System (EIAS) between September 2009 and June 2022. The cohort was analyzed and evaluated regarding risk factors for AL. Results Altogether 10,632 patients were included, 10,219 were without AL and 413 (3.9%) were with AL. After adjusted analysis, male sex (4.6% AL), OR: 1.49; 95% CI (1.16–1.90), obesity (4.8% AL), OR: 1.62; 95% CI (1.18–2.24), previous surgery (4.4% AL), OR: 1.45; 95% CI (1.14–1.86), open surgery (4.4% AL), OR: 1.36; 95% CI (1.02–1.83), anastomosis between small bowel and rectum (13.1% AL), OR: 3.97; 95% CI (2.23–7.10), stapled anastomosis (5.3% AL), OR: 2.46; 95% CI (1.79–3.38), inhalation anesthesia (4.2% AL), OR: 1.80; 95% CI (1.26–2.57), and conversion to open surgery (5.5% AL), OR 1.49; 95% CI (1.02–2.19) were significant risk factors for AL. Although pre and intraoperative compliance to the ERAS‐protocol was similar, excess of fluids day 0 was an independent predictor for AL. Conclusion Male sex, obesity, previous surgery, open surgery, stapled anastomotic technique, anastomosis between small bowel and rectum, inhalation anesthesia, conversion to open surgery, and among ERAS interventions, excess of fluids day 0, were significant risk factors for AL.

surgery
Application value of modified serf-traction Overlap method in intrathoracic esophagogastrostomy of Ivor Lewis surgery

Yong Fang,Weigang Guo,Lijie Tan,Jun Yin,Miao Lin,Xiaosang Chen,Han Tang

DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2019.03.014

2019-01-01

Abstract:Objective To explore the application value of modified self-traction Overlap method in intrathoracic esophagogastrostomy of Ivor Lewis surgery.Methods The retrospective and descriptive study was conducted.The clinical data of 12 patients with lower esophageal carcinoma who underwent Ivor Lewis surgery in the Zhongshan Hospital of Fudan University from January to May 2018 were collected.There were 9 males and 3 females,aged from 50 to 73 years,with a median age of 61 years.Modified self-traction Overlap method was used for intrathoracic esophagogastrostomy during the surgery.The esophagus was pulled down with the ligature as traction and rotated clockwise by 45 degrees to perform side-to-side esophagogastric anastomosis.The common opening was closed by a laparoscopic linear cutting suturing device to form an esophagogastric Overlap triangle anastomosis,and finally the esophagus was disconnected.Observation indicators:(1) intraoperative and postoperative situations;(2) follow-up situations.Follow-up using outpatient examination and telephone interview was performed to detect survival situation and tumor recurrence and metastasis up to January 2019.Measurement data were described as M (range).Results (1) Intraoperative and postoperative situations:all the 12 patients underwent successful Ivor Lewis surgery,without conversion to open surgery.The operation time,time of tubular gastroesophageal anastomosis,volume of intraoperative blood loss,time to initial anal exsufflation and time for initial fluid diet intake were 145 minutes (range,125-189 minutes),20 minutes (range,16-35 minutes),98 mL (range,78-135 mL),4 days (range,3-5 days),6 days (range,5-7 days),respectively.All the patients had no complication.Patients underwent upper gastrointestinal iodine hydrography at 5 days after surgery,confirming no anastomotic leakage or stenosis.Patients recovered well and were discharged postoperatively.The duration of postoperative hospital stay was 8 days (range,7-11 days).(2) Follow-up situations:12 patients were followed up for 8.0-12.0 months,with a median time of 10.6 months.Patients survived well,with no tumor recurrence or metastasis.Condusion Modified self-traction Overlap method in thoracic esophagogastrostomy of Ivor Lewis surgery is safe and feasible for lower esophageal carcinoma,with easy operating
Effect of air travel on the spread of an avian influenza pandemic to the United States

N. Tuncer,T. T. Le

DOI: https://doi.org/10.1016/j.ijcip.2014.02.001

IF: 3.683

2014-02-07

International Journal of Critical Infrastructure Protection

Abstract:
Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment

M Fabbi,E R C Hagens,M I van Berge Henegouwen,S S Gisbertz

DOI: https://doi.org/10.1093/dote/doaa039

2020-06-01

Diseases of the Esophagus

Abstract:Summary Anastomotic leakage is one of the most severe complications after esophagectomy and is associated with increased postoperative morbidity and mortality. Several projects ranging from small retrospective studies to large collaborations have aimed to identify potential pre- and perioperative risk factors and to improve the diagnostic processes and management. Despite the increase in available literature, many aspects of anastomotic leakage are still debated, without the existence of widely accepted guidelines. The purpose of this review is to provide a cutting edge overview of the recent literature regarding the definition and classification of anastomotic leakage, risk factors, novel diagnostic modalities, and emerging therapeutic options for treatment and prevention of anastomotic leakage following esophagectomy.

gastroenterology & hepatology
Endoscope-assisted Mediastinal Drainage Therapy for Anastomosis Leakage after Esophagectomy: a Retrospective Cohort Study.

Wei Guo,Lianggang Zhu,Yuquan Wu,Su Yang,Hailei Du,Xiang Zhou,Jiaming Che,Junbiao Hang,Hecheng Li

DOI: https://doi.org/10.21037/atm.2019.11.103

IF: 3.616

2019-01-01

Annals of Translational Medicine

Abstract:BACKGROUND:Anastomosis leakage after esophagectomy is a major threat which leads to many subsequent complications even mortality. But current diagnosis and treatment methods are inefficient. This retrospective study aims to evaluate the utilization of endoscope-assisted mediastinal drainage therapy in treatment for anastomosis leakage after esophagectomy.METHODS:Between January 2014 and June 2018, 51 patients were confirmed anastomosis leakage using gastroscopy. Of them, 23 patients were treated with endoscope-assisted mediastinal drainage therapy (drainage group); and the other 28 patients received endoscope-assisted biomedical fibrin glue occlusion (occlusion group). Short-term clinical outcomes were examined. Factors related to length of postoperative hospitalization (LPH) was analyzed.RESULTS:Endoscope provided highly accurate information on the condition of anastomosis leakage. And there was no evidence that early endoscopy could cause damage to the anastomosis or gastric conduit. One patient from drainage group and two from occlusion group discharged against medical advice. Other 48 patients were completely cured without reoperation or mortality. The median LPH was 32 days in drainage group (range from 17 to 80 days) and 81 days in occlusion group (range from 32 to 190 days), respectively (P<0.05). Linear regression indicated statistically significant correlation between LPH and length from diagnosis to drainage or occlusion (R=0.688, P<0.001).CONCLUSIONS:Endoscope-assisted mediastinal drainage therapy is a satisfactory treatment for anastomosis leakage. Early diagnosis and treatment may facilitate the recovery of anastomosis leakage and reduce LPH.
Risk factors for and treatment of anastomotic strictures after Ivor Lewis esophagectomy

Sophie L. F. Doran,Maria G. Digby,Sophie V. Green,Clive J. Kelty,Anand P. Tamhankar

DOI: https://doi.org/10.1007/s00464-024-11150-w

2024-08-22

Surgical Endoscopy

Abstract:Anastomotic strictures following esophagectomy occur frequently and impact on nutrition and quality of life. Although strictures are often attributed to ischemia and anastomotic leaks, the role of anastomosis size and pyloroplasty is not well evaluated. Our study aims to assess the rate of and risk factors for anastomotic stricture following esophagectomy, and the impact of treatment with regular endoscopic balloon dilatations.

surgery
Laparoscopic and Thoracoscopic Ivor Lewis Esophagectomy Using a Circular-Stapled Anastomosis with Trans-Oral Anvil: 30 Cases Report

SHEN Gang,WU Ming,WANG Qi,ZHANG Sai,FAN Junqiang,CHAI Ying

DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2012.05.002

2012-01-01

Abstract:Objective To explore the feasibility and short-term efficacy of laparoscopic and thoracoscopic Ivor Lewis esophagectomy using a circular-stapled anastomosis with trans-oral anvil in treating esophageal carcinoma.Methods 30 consecutive patients with esophageal cancer received minimally invasive Ivor Lewis esophagectomy from January 2011 to December 2011.Operations of all the cases comprised of both abdominal and thoracic procedures which were performed with Iaparoscopic and thoracoscopic techniques respectively.The intrathoracic esophago-gastric anastomosis was created using a circular-stapled anastomosis with trans-oral anvil technique.Results There were 24 males and 6 female with median age of 62.5-year-old (from 47 to 82).The lesions located in middle and/or lower portion of the esophagus.25 patients with esophageal squamous cell cancer (n =25) and 5 patients with adenocarcinoma (n =5) underwent an Ivor Lewis esophagectomy.All the operations were successfully performed without intra-operative technical failures of the anastomosis or deaths.The mean operation time was 95 minutes in abdomen and 177 minutes in thorax.The mean blood loss was 310 ml.The mean number of harvested lymph nodes was 10.6 from thorax and 4.9 from abdomen.Postoperalively,there were thoracic wound infections in 4 patients.One patient had a left diaphragmatic hernia and was successfully treated by re-operation 6 days after first operation.One patient had chylothorax and recovered without surgery.There was no anastomotic leak and the patients were able to have spoon meat at 5.6 postoperative days.Conclusion Laparoscopic and thoracoscopic Ivor Lewis esophagectomy can be accomplished smoothly with acceptable occurrence of complications.The circular-stapled anastomosis with the trans-oral anvil is an efficient,safe and reproducible technique for intrathoracic esophago-gastric anastomosis.
Postoperative superior anastomotic leakage classification and treatment strategy for postoperative esophagogastric junction cancer

Junli Zhang,Changzheng Li,Pengfei Ma,Yanghui Cao,Janusz Włodarczyk,Mohsen Ibrahim,Chenyu Liu,Sen Li,Xijie Zhang,Guangsen Han,Yuzhou Zhao

DOI: https://doi.org/10.21037/jgo-23-968

2024-02-29

Abstract:Background: At present, anastomotic fistula cannot be avoided after adenocarcinoma of the esophagogastric junction (AEG). Once the anastomotic leakage occurs, the posterior mediastinum and the left thoracic cavity are often seriously infected, which further impairs respiratory and circulatory function, heightening the danger of the disease course. The aim of this study was to identify the characteristics of superior anastomotic leakage after surgery for AEG and recommend corresponding treatment strategies to improve the diagnosis and treatment of superior anastomotic leakage after surgery for AEG. Methods: The clinical data of 57 patients with superior anastomotic leakage after surgery for AEG in the Affiliated Cancer Hospital of Zhengzhou University from January 2017 to March 2019 were retrospectively analyzed, including 27 cases referred from external hospitals and 30 cases at the Affiliated Cancer Hospital of Zhengzhou University. According to the diameter and risk level of anastomotic leakage, the high anastomotic leakage is divided into types I, II, III, and IV. Results: Patients with preoperative comorbidities or those treated with the transabdominal approach or laparoscopic surgery often had type I and type II anastomotic leakage; meanwhile, patients with preoperative comorbidities and sacral perforation or those treated with a thoracic and abdominal approach or open surgery often had type III and IV fistula. The difference between types I-II and types III-IV was statistically significant (P<0.05). The mortality rate of patients with type III and type IV leakage was 14.8% within 90 days after operation, while no deaths occurred among patients with type I and type II leakage, and the difference in mortality between the two groups was statistically significant (P<0.05). Conclusions: After surgery for AEG, suitable treatment measures should be adopted according to the type of superior anastomotic leakage that occurs. Types III and IV superior anastomotic leakages are associated with higher mortality and require greater attention from surgeons.
A 10-year experience with anastomotic leaks in upper gastrointestinal surgery–Retrospective cohort study

Jia-Hao Law,Charmaine Zhi-Mei Ng,Sarah-Kei Lauw,Jimmy Bok Yan So,Guowei Kim,Asim Shabbir

DOI: https://doi.org/10.1016/j.surge.2023.11.001

IF: 2.632

2024-01-03

The Surgeon

Abstract:Background Anastomotic leak (AL) in upper gastrointestinal (UGI) surgery continues to be a diagnostic challenge. We seek to identify clinical parameters that predict AL and examine the effectiveness of investigations in evaluating AL following UGI surgeries. Methods 592 patients underwent UGI surgeries with an anastomosis between January 2011 and January 2021. Data on patient characteristics, surgery, postoperative investigations and outcomes were prospectively collected and analysed. Results The overall occurrence of AL was 6.4 %. Tachycardia >120 BPM (OR 6.959, 95 % CI 1.856–26.100, p = 0.004) and leukocyte count >19 × 10 9 /L (OR 3.327, 95 % CI 1.009–10.967, p = 0.048) were independent predictors of AL. On multivariate analysis, patients whose anastomosis was deemed high risk and had pre-emptive investigation done postoperatively to exclude a leak were less likely to require intervention and were more likely to be managed conservatively (66.7 % vs 14.3 %, p = 0.025). Methylene blue test, oral contrast study and Computed Tomography scan with intravenous and oral contrast had 50.0 %, 20.0 % and 9.1 % false negative results, while esophagogastroduodenoscopy had none. There was no misdiagnosed AL when more than 1 investigation (n = 15, 39.5 %) were performed. Conclusion Our study demonstrates that the presence of a triad including desaturation , tachycardia and leucocytosis predicts for AL following UGI surgery and for confirmation of a leak, evaluation with 2 or more investigation is needed. A practice of evaluating high risk anastomosis prior to commencement of feeding decreased the need for surgical intervention and improves success of conservative treatment.

surgery
Incidence and risk factors for anastomotic bile leakage in hepatic resection with bilioenteric reconstruction - A international multicenter study

Eva Braunwarth,Francesca Ratti,Luca Aldrighetti,Hasan A Al-Saffar,Melroy A D Souza,Christian Sturesson,Richard Linke,Andreas Schnitzbauer,Martin Bodingbauer,Klaus Kaczirek,Daniel Vagg,Giles Toogood,Daniele Ferraro,Giuseppe K Fusai,Rafael Diaz-Nieto,Hassan Malik,Frederik J H Hoogwater,Doris Wagner,Peter Kornprat,Ines Fischer,Reinhold Függer,Georg Göbel,Dietmar Öfner,Stefan Stättner

DOI: https://doi.org/10.1016/j.hpb.2022.08.009

Abstract:Background: Anastomotic leak (AL) after bilioenteric reconstruction (BR) is a feared complication after bile duct resection, especially in combination with liver resection. Literature on surgical outcome is sparse. This study aimed to determine the incidence and risk factors for AL after combined liver and bile duct resection with a focus on operative or endoscopic reinterventions. Methods: Data from consecutive patients who underwent liver resection and BR between 2004 and 2018 in 11 academic institutions in Europe were collected from prospectively maintained databases. Results: Within 921 patients, AL rate was 5.4% with a 30d mortality of 9.6%. Pringle maneuver (p<0.001),postoperative external biliary (p=0.007) and abdominal drainage (p<0.001) were risk factors for clinically relevant AL. Preoperative biliary drainage (p<0.001) was not associated with a higher rate of AL. AL was more frequent in stented patients (76.5%) compared to PTCD (17.6%) or PTCD+stent (5.9%,p=0.017). AL correlated with increased incidence of postoperative liver failure (p=0.036), cholangitis, hemorrhage and sepsis (all p<0.001). Conclusion: This multicenter data provides the largest series to date of LR with BR and could help in the management of these patients which are often challenging and hampering the patients' postoperative course negatively.
Management of esophageal anastomotic leaks, a systematic review and network meta-analysis

William Murray,Mathew G Davey,William Robb,Noel E Donlon

DOI: https://doi.org/10.1093/dote/doae019

2024-03-24

Diseases of the Esophagus

Abstract:Summary There is currently no consensus as to how to manage esophageal anastomotic leaks. Intervention with endoscopic vacuum-assisted closure (EVAC), stenting, reoperation, and conservative management have all been mooted as potential options. To conduct a systematic review and network meta-analysis (NMA) to evaluate the optimal management strategy for esophageal anastomotic leaks. A systematic review was performed as per the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines with extension for NMA. NMA was performed using R packages and Shiny. In total, 12 retrospective studies were included, which included 511 patients. Of the 449 patients for whom data regarding sex was available, 371 (82.6%) were male, 78 (17.4%) were female. The average age of patients was 62.6 years (standard deviation 10.2). The stenting cohort included 245 (47.9%) patients. The EVAC cohort included 123 (24.1%) patients. The conservative cohort included 87 (17.0%) patients. The reoperation cohort included 56 (10.9%) patients. EVAC had a significantly decreased complication rate compared to stenting (odds ratio 0.23 95%, confidence interval [CI] 0.09;0.58). EVAC had a significantly lower mortality rate than stenting (odds ratio 0.43, 95% CI 0.21; 0.87). Reoperation was used in significantly larger leaks than stenting (mean difference 14.66, 95% CI 4.61;24.70). The growing use of EVAC as a first-line intervention in esophageal anastomotic leaks should continue given its proven effectiveness and significant reduction in both complication and mortality rates. Surgical management is often necessary for significantly larger leaks and will likely remain an effective option in uncontained leaks with systemic features.

gastroenterology & hepatology
Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks

Marc Bludau,Hans F. Fuchs,Till Herbold,Martin K. H. Maus,Hakan Alakus,Felix Popp,Jessica M. Leers,Christiane J. Bruns,Arnulf H. Hölscher,Wolfgang Schröder,Seung-Hun Chon

DOI: https://doi.org/10.1007/s00464-017-5883-4

2017-12-07

Surgical Endoscopy

Abstract:BackgroundEsophageal perforations and postoperative leakage of esophagogastrostomies are considered to be life-threatening conditions due to the potential development of mediastinitis and consecutive sepsis. Vacuum-assisted closure (VAC) techniques, a well-established treatment method for superficial infected wounds, are based on a negative pressure applied to the wound via a vacuum-sealed sponge. Endoluminal VAC (E-VAC) therapy as a treatment for GI leakages in the rectum was introduced in 2008. E-VAC therapy is a novel method, and experience regarding esophageal applications is limited. In this retrospective study, the experience of a high-volume center for upper GI surgery with E-VAC therapy in patients with leaks of the upper GI tract is summarized. To our knowledge, this series presents the largest patient cohort worldwide in a single-center study.MethodsBetween October 2010 and January 2017, 77 patients with defects in the upper gastrointestinal tract were treated using the E-VAC application. Six patients had a spontaneous perforation, 12 patients an iatrogenic injury, and 59 patients a postoperative leakage in the upper gastrointestinal tract.ResultsComplete restoration of the esophageal defect was achieved in 60 of 77 patients. The average duration of application was 11.0 days, and a median of 2.75 E-VAC systems were used. For 21 of the 77 patients, E-VAC therapy was combined with the placement of self-expanding metal stents.ConclusionThis study demonstrates that E-VAC therapy provides an additional treatment option for esophageal wall defects. Esophageal defects and mediastinal abscesses can be treated with E-VAC therapy where endoscopic stenting may not be possible. A prospective multi-center study has to be directed to bring evidence to the superiority of E-VAC therapy for patients suffering from upper GI defects.

The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.

Suction Drainage for Anastomotic Leakage After Ivor Lewis Esophagectomy

Outcome of Self-Expanding Metal Stents in the Treatment of Anastomotic Leaks After Ivor Lewis Esophagectomy

[STUDY USING RADIOACTIVE CALCIUM (45CA) IN HYPERPARATHYROIDISM].

Anastomotic Leakages after Surgery for Gastroesophageal Cancer: A Systematic Review and Meta-Analysis on Endoscopic versus Surgical Management

Outcomes of Esophageal Stent Therapy for the Management of Anastomotic Leaks

Endoscopic Naso-Leakage Drainage: a Safe and Effective Method for the Management of Intrathoracic Anastomotic Leakage after Esophagectomy.

Differences in the pattern of anastomotic leakage after oesophagectomy in two high-volume centres

Effect of Neoadjuvant Therapy on Endoluminal Vacuum-Assisted Closure Therapy (EVAC) for Anastomotic Leakage After Oesophagectomy

Risk factors for anastomotic leakage in colonic procedures within an ERAS‐protocol. A retrospective cohort study from the Swedish part of the international ERAS‐database

Application value of modified serf-traction Overlap method in intrathoracic esophagogastrostomy of Ivor Lewis surgery

Effect of air travel on the spread of an avian influenza pandemic to the United States

Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment

Endoscope-assisted Mediastinal Drainage Therapy for Anastomosis Leakage after Esophagectomy: a Retrospective Cohort Study.

Risk factors for and treatment of anastomotic strictures after Ivor Lewis esophagectomy

Laparoscopic and Thoracoscopic Ivor Lewis Esophagectomy Using a Circular-Stapled Anastomosis with Trans-Oral Anvil: 30 Cases Report

Postoperative superior anastomotic leakage classification and treatment strategy for postoperative esophagogastric junction cancer

A 10-year experience with anastomotic leaks in upper gastrointestinal surgery–Retrospective cohort study

Incidence and risk factors for anastomotic bile leakage in hepatic resection with bilioenteric reconstruction - A international multicenter study

Management of esophageal anastomotic leaks, a systematic review and network meta-analysis

Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks